182.48
price down icon0.39%   -0.7506
 
loading
Quest Diagnostics Inc stock is traded at $182.48, with a volume of 436.06K. It is down -0.39% in the last 24 hours and down -2.30% over the past month. Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$183.23
Open:
$183.99
24h Volume:
436.06K
Relative Volume:
0.48
Market Cap:
$20.40B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.82
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
-3.69%
1M Performance:
-2.30%
6M Performance:
+3.78%
1Y Performance:
+15.53%
1-Day Range:
Value
$181.94
$184.73
1-Week Range:
Value
$179.53
$197.55
52-Week Range:
Value
$148.70
$197.55

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Name
Quest Diagnostics Inc
Name
Phone
(973) 520-2700
Name
Address
500 PLAZA DRIVE, SECAUCUS
Name
Employee
56,000
Name
Twitter
@QuestDX
Name
Next Earnings Date
2025-10-21
Name
Latest SEC Filings
Name
DGX's Discussions on Twitter

Compare DGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
182.44 20.38B 10.52B 999.00M 1.22B 8.3628
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
574.28 215.96B 43.74B 6.59B 6.17B 17.30
Diagnostics & Research icon
DHR
Danaher Corp
223.21 157.33B 24.27B 3.50B 4.86B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
643.07 51.09B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
147.96 41.80B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
221.14 37.38B 15.70B 1.24B 2.01B 6.9036

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-25-25 Downgrade Robert W. Baird Outperform → Neutral
Apr-02-25 Initiated Redburn Atlantic Buy
Mar-04-25 Downgrade Citigroup Buy → Neutral
Jan-06-25 Upgrade Leerink Partners Market Perform → Outperform
Dec-17-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-10-24 Resumed Jefferies Buy
Oct-23-24 Upgrade Robert W. Baird Neutral → Outperform
Aug-28-24 Resumed Evercore ISI In-line
Jul-10-24 Upgrade Citigroup Neutral → Buy
Feb-26-24 Initiated Leerink Partners Market Perform
Feb-07-24 Upgrade Jefferies Hold → Buy
Jan-03-24 Initiated Barclays Equal Weight
Dec-12-23 Upgrade BofA Securities Neutral → Buy
Jun-29-23 Initiated Piper Sandler Neutral
May-02-23 Downgrade BofA Securities Buy → Neutral
Apr-03-23 Upgrade Citigroup Sell → Neutral
Jan-23-23 Initiated Evercore ISI In-line
Nov-17-22 Downgrade Citigroup Neutral → Sell
Aug-22-22 Resumed Morgan Stanley Equal-Weight
Apr-04-22 Downgrade Citigroup Buy → Neutral
Feb-23-22 Downgrade UBS Buy → Neutral
Feb-02-22 Downgrade Jefferies Buy → Hold
Jan-28-22 Downgrade Deutsche Bank Buy → Hold
May-04-21 Upgrade UBS Neutral → Buy
Mar-12-21 Downgrade Robert W. Baird Outperform → Neutral
Oct-21-20 Upgrade Argus Hold → Buy
Jul-29-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jul-14-20 Upgrade BofA Securities Neutral → Buy
Jun-09-20 Upgrade Wells Fargo Underweight → Equal Weight
Jun-02-20 Upgrade Deutsche Bank Hold → Buy
Apr-28-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-27-20 Upgrade Citigroup Neutral → Buy
Apr-27-20 Upgrade Wolfe Research Underperform → Peer Perform
Mar-27-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Downgrade Barclays Overweight → Equal Weight
Dec-19-19 Upgrade BofA/Merrill Underperform → Neutral
Jul-15-19 Downgrade Goldman Neutral → Sell
Apr-02-19 Upgrade Jefferies Hold → Buy
Mar-18-19 Resumed Credit Suisse Neutral
Jan-31-19 Downgrade Argus Buy → Hold
Jan-17-19 Initiated UBS Neutral
Jan-03-19 Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18 Downgrade BofA/Merrill Buy → Neutral
Nov-30-18 Downgrade Goldman Buy → Neutral
View All

Quest Diagnostics Inc Stock (DGX) Latest News

pulisher
12:22 PM

JPMorgan Adjusts Quest Diagnostics Price Target to $205 From $190 - MarketScreener

12:22 PM
pulisher
09:35 AM

Is Quest Diagnostics Incorporated stock in correction or buying zoneGold Moves & Free Safe Entry Trade Signal Reports - newser.com

09:35 AM
pulisher
09:34 AM

Exit strategy if you’re trapped in Quest Diagnostics Incorporated2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

09:34 AM
pulisher
06:22 AM

Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceMarket Weekly Review & Precise Swing Trade Alerts - newser.com

06:22 AM
pulisher
01:07 AM

How currency fluctuations impact Quest Diagnostics Incorporated stockRate Cut & High Conviction Buy Zone Picks - newser.com

01:07 AM
pulisher
12:59 PM

Can Quest Diagnostics Incorporated stock surprise with earnings upsideJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com

12:59 PM
pulisher
Oct 23, 2025

Argus Lifts Price Target on Quest Diagnostics to $210 From $195 - MarketScreener

Oct 23, 2025
pulisher
Oct 23, 2025

Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

How to escape a deep drawdown in Quest Diagnostics IncorporatedWeekly Trend Summary & Target Return Focused Picks - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

How supply chain issues affect Quest Diagnostics Incorporated stockMarket Weekly Review & Growth Focused Investment Plans - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How dovish Fed policy supports Quest Diagnostics Incorporated stockPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What Fibonacci levels say about Quest Diagnostics Incorporated reboundWeekly Earnings Recap & Low Risk High Reward Ideas - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Will Quest Diagnostics Incorporated stock return to pre crisis levelsQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Incorporated (DGX): A Bull Case Theory - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead (NYSE:DGX) - Seeking Alpha

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings - Benzinga

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Sees Solid Demand Even As Margins Slip - Finimize

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Margins a Blip as Fundamentals Stay Strong, Morgan Stanley Says - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock - sharewise.com

Oct 22, 2025
pulisher
Oct 22, 2025

Barclays Lifts Price Target on Quest Diagnostics to $195 From $190, Maintains Equalweight Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Reports Third Quarter 2025 Financial Results, Raises Guidance for Full Year 2025 - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Morgan Stanley Raises Price Target on Quest Diagnostics to $207 From $191, Keeps Overweight Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics (DGX): 15.4% Earnings Growth Challenges Slower-Growth Narrative - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics: Q3 Earnings Snapshot - Stamford Advocate

Oct 22, 2025
pulisher
Oct 22, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Oct 22, 2025
pulisher
Oct 21, 2025

Will Quest Diagnostics Incorporated stock profit from fiscal stimulus2025 Dividend Review & Breakout Confirmation Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Jefferies Maintains Quest Diagnostics (DGX) Buy Recommendation - Nasdaq

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-21 17:43:02 - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Leerink Partners Raises Price Target for Quest Diagnostics (DGX) to $210 | DGX Stock News - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Why Quest Diagnostics Incorporated stock is a strong buy call2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: St - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Leerink Partners Adjusts PT on Quest Diagnostics to $210 From $203, Maintains Outperform Rating - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Reports Q3 Earnings, Shares Slide - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Incorporated Revises Financial Guidance for the Full Year Ending December 31, 2025 - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics shares rise as strong clinical demand drives earnings beat - Investing.com Australia

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Ups Forecasts As Diagnostic Test Demand Rises - Finimize

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Q3 2025 Earnings: Revenue Surpasses Estimates at $2.82 Billion, Adjusted EPS at $2.60 - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Q3 Adjusted Earnings, Revenue Rise; Annual Outlook Upgraded -- Shares Up Pre-Bell - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Delivers Strong Growth And Raises Guidance - Finimize

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics raises annual profit and revenue forecasts on lab test demand - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics (DGX) Exceeds Q3 Projections with Strong Finan - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Quest (NYSE:DGX) Posts Better-Than-Expected Sales In Q3 - The Globe and Mail

Oct 21, 2025

Quest Diagnostics Inc Stock (DGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$358.06
price up icon 0.65%
diagnostics_research LH
$279.58
price down icon 1.56%
$192.12
price down icon 1.36%
diagnostics_research MTD
$1,434.91
price down icon 0.11%
diagnostics_research IQV
$221.19
price up icon 0.59%
Cap:     |  Volume (24h):